000 | 01981 a2200481 4500 | ||
---|---|---|---|
005 | 20250514035646.0 | ||
264 | 0 | _c20030108 | |
008 | 200301s 0 0 eng d | ||
022 | _a0001-6772 | ||
024 | 7 |
_a10.1046/j.1365-201X.2002.00987.x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGavin, T P | |
245 | 0 | 0 |
_aAttenuation of the exercise-induced increase in skeletal muscle Flt-1 mRNA by nitric oxide synthase inhibition. _h[electronic resource] |
260 |
_bActa physiologica Scandinavica _cJul 2002 |
||
300 |
_a201-9 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aEndothelial Growth Factors |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 |
_aExtracellular Matrix Proteins _xdrug effects |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 | _aIntercellular Signaling Peptides and Proteins |
650 | 0 | 4 | _aLymphokines |
650 | 0 | 4 |
_aMuscle, Skeletal _xphysiology |
650 | 0 | 4 |
_aNG-Nitroarginine Methyl Ester _xanalogs & derivatives |
650 | 0 | 4 |
_aNitric Oxide Synthase _xantagonists & inhibitors |
650 | 0 | 4 |
_aPhysical Exertion _xphysiology |
650 | 0 | 4 |
_aRNA, Messenger _xmetabolism |
650 | 0 | 4 |
_aRNA, Ribosomal, 18S _xgenetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aSensitivity and Specificity |
650 | 0 | 4 | _aVascular Endothelial Growth Factor A |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-1 _xgenetics |
650 | 0 | 4 |
_aVascular Endothelial Growth Factor Receptor-2 _xgenetics |
650 | 0 | 4 | _aVascular Endothelial Growth Factors |
700 | 1 | _aWagner, P D | |
773 | 0 |
_tActa physiologica Scandinavica _gvol. 175 _gno. 3 _gp. 201-9 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1046/j.1365-201X.2002.00987.x _zAvailable from publisher's website |
999 |
_c11994008 _d11994008 |